Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, South Korea.
Int J Gynecol Cancer. 2011 May;21(4):699-705. doi: 10.1111/IGC.0b013e3181e94349.
We evaluated the metabolic response of lymph nodes (LNs) using consecutive F-fluorodeoxyglucose-positron emission tomography/computed tomography (PET/CT) and correlated the metabolic response with the volumetric response measured by consecutive CT.
Twenty-two patients with cervical cancer that had positive LNs underwent preradiotherapy (pre-RT) and inter-RT PET/CT. The metabolic response of the LNs was assessed quantitatively and semiquantitatively by measurement of the maximal standardized uptake value. All patients underwent inter-RT CT simulation after 45 Gy to the whole pelvis and inter-RT PET/CT scans after median 63 Gy to the gross LNs.
A total of 48 pelvic and para-aortic LNs were found on the pre-RT PET/CT. The mean maximal standardized uptake value of nodal disease decreased from the pre-RT of 5.2 (SD, 3.1; range, 1.8-15.6) to the inter-RT of 1.1 (SD, 2.1; range, 0-11.1). Classifying the metabolic response of all 48 nodal lesions on the inter-RT PET/CT, 38 had a complete metabolic response. The initial volume of LNs had no correlation with the metabolic response (r = 0.194, P = 0.186). The metabolic response between the pre-RT PET/CT and inter-RT PET/CT was significantly associated with the volume response between the pre-RT CT and inter-RT CT (r = 0.314, P < 0.05). However, 18 (38%) LNs showed discrepancy between metabolic response and residual LN volume. Six (27%) patients had modified RT during treatment based on inter-RT PET/CT.
We suggest that the PET/CT can be a useful tool for the evaluation of the interim response of the LNs and aid in selecting patients that need further treatment. The results showed a significant correlation between the metabolic and volumetric responses during RT, although the anatomical changes of LNs would not always represent the metabolic status.
我们通过连续氟-18 脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(PET/CT)评估淋巴结(LN)的代谢反应,并将代谢反应与连续 CT 测量的体积反应相关联。
22 例经证实存在阳性 LN 的宫颈癌患者接受了放疗前(pre-RT)和放疗中(inter-RT)PET/CT。通过测量最大标准化摄取值对 LN 的代谢反应进行定量和半定量评估。所有患者在全骨盆接受 45 Gy 放疗后进行 inter-RT CT 模拟,在接受中位 63 Gy 放疗至大体 LN 后进行 inter-RT PET/CT 扫描。
在 pre-RT PET/CT 上共发现 48 个盆腔和腹主动脉旁 LN。肿瘤病变的最大标准化摄取值从 pre-RT 的 5.2(标准差[SD],3.1;范围,1.8-15.6)下降到 inter-RT 的 1.1(SD,2.1;范围,0-11.1)。根据 inter-RT PET/CT 对所有 48 个淋巴结病变的代谢反应进行分类,38 个有完全代谢反应。LN 的初始体积与代谢反应无相关性(r=0.194,P=0.186)。pre-RT PET/CT 和 inter-RT PET/CT 之间的代谢反应与 pre-RT CT 和 inter-RT CT 之间的体积反应显著相关(r=0.314,P<0.05)。然而,18 个(38%)LN 的代谢反应和残留 LN 体积之间存在差异。6 例(27%)患者根据 inter-RT PET/CT 改变了 RT 方案。
我们认为 PET/CT 可以作为评估 LN 中期反应的有用工具,并有助于选择需要进一步治疗的患者。结果显示,在 RT 过程中代谢反应和体积反应之间存在显著相关性,尽管 LN 的解剖变化并不总是代表其代谢状态。